← Evidence map

TrialHaematologica2016

ENGAGE- 501: phase II study of entinostat (SNDX-275) in relapsed and refractory Hodgkin lymphoma.

Connie Lee Batlevi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27151994